Niramai
Pre-clinicalNiramai provides AI-driven breast cancer screening with accurate, non-invasive, radiation-free early detection, available in 200+ hospitals across 30 cities
Founded
2016
Focus
AI / Machine LearningDiagnostics
About
Niramai provides AI-driven breast cancer screening with accurate, non-invasive, radiation-free early detection, available in 200+ hospitals across 30 cities
Funding History
2Total raised: $16M
Series B$10MBessemer Venture PartnersFeb 15, 2021
Series A$6Mpi VenturesJan 15, 2019
Company Info
TypePrivate
Founded2016
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile